Document is current
Any future updates will be listed below
-
Authors
Ramlal, Reshma
Kim, Jongphil https://orcid.org/0000-0002-7430-2226
Thompson, Zachary
Ochoa-Bayona, Leonel
Mishra, Asmita https://orcid.org/0000-0003-3065-4294
Nishihori, Taiga https://orcid.org/0000-0002-2621-7924
Perez, Lia
Bejanyan, Nelli https://orcid.org/0000-0003-0194-7338
Castaneda Puglianini, Omar https://orcid.org/0000-0003-0423-5870
Faramand, Rawan
Mirza, Sayeef https://orcid.org/0000-0002-1875-8966
Khimani, Farhad https://orcid.org/0000-0003-4828-4711
Lazaryan, Aleksandr https://orcid.org/0000-0001-9605-6436
Hansen, Doris https://orcid.org/0000-0002-9813-3578
Locke, Frederick https://orcid.org/0000-0001-9063-6691
Artz, Andrew https://orcid.org/0000-0003-0803-9607
Sorror, Mohamed
Pidala, Joseph https://orcid.org/0009-0005-7693-7398
- License Information
-
More Information
Article History
Received: 13 January 2026
Revised: 6 February 2026
Accepted: 9 March 2026
First Online: 8 April 2026
Competing interests
: RR: none. JK: none. ZT: none. AM: none. TN: Research funding Novartis, Kary pharm. LP: none. NB : Consulting or advisory role: Cared, Medexus Pharmaceuticals, ORCA Biosystems, Allovers, TScan Therapeutics, and Pfizer. Research finding: CRISPR Therapeutics. OCP: Honoraria for consultancy with Legend Biotech Inc, Bristol Myers Squibb, and Janssen Biotech Inc. OCP: Honoraria for consultancy with Legend Biotech Inc, Bristol Myers Squibb, and Janssen Biotech Inc. RF: Advisory Board: Kite/Gilead, Autobus Consultancy: Sanofi. Institutional research funding: Novartis. SM: Consultancy: Bristol Myers Squibb. FK: none. AL: SAB/Consultancy/Honoraria: Incyte, Sanofi, Pierre Fabre. DH: Research funding from Bristol-Myers Squibb, Janssen, Karyopharm, Kite Pharma, and Adaptive Biotech; Consulting or advisory role for Bristol Myers Squibb, Janssen, Legend Biotech, Pfizer, Kite Pharma/Gilead Sciences, AstraZeneca, and Karyopharm. FL: Consultancy: Pfizer, Legend Biotech, Bluebird Bio, Sana, Miltenyi, Iovance, BMS, Adaptive Biotechnologies, Adaptimmune, Allogene, Astra-Zeneca, 2SeventyBio, Kite Pharma, Caribou, Amgene, Janssen. AA: Daichii Sanyko consultant. Astra Zeneca consultant. MS: Advisory and speaker roles for JAZZ pharmaceuticals – Canada. JP: Consulting and advisory board membership – Syndax, CTI Biopharma, Amgen, Regeneron, Incyte, Sanofi; Clinical trial support - Novartis, Amgen, Takeda, Janssen, Johnson and Johnson, Pharmacyclics, Abbvie, CTI Biopharma, BMS.
